Cargando…
The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials
Facial seborrheic dermatitis (SD) is a chronic inflammatory skin condition that can affect the quality of life with frequent recurrences. There is no medication as yet to cure this disease completely. There are four general categories of agents that are used to treat SD: antifungal agents, keratolyt...
Autores principales: | Alsmeirat, Odeh, Lakhani, Som, Egaimi, Musab, Idris, Osama, Elkhalifa, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436712/ https://www.ncbi.nlm.nih.gov/pubmed/36072203 http://dx.doi.org/10.7759/cureus.27622 |
Ejemplares similares
-
Lipoid Proteinosis Masquerading as Seborrheic Dermatitis
por: Tripathi, Alka, et al.
Publicado: (2021) -
Treatment of Facial Seborrheic Dermatitis with Pimecrolimus Cream 1%: An Open-Label Clinical Study in Korean Patients
por: Kim, Byung-Soo, et al.
Publicado: (2007) -
Seborrheic Dermatitis-Like Eruption Induced by Isotretinoin: A Case Report
por: Alharbi, Aymen, et al.
Publicado: (2023) -
A Clinicoepidemiological Study of Cutaneous and Systemic Comorbidities of Seborrheic Dermatitis in Adolescent and Adult Females
por: T S, Rajashekar, et al.
Publicado: (2023) -
Morphologic Mimickers of Seborrheic Keratoses: Cutaneous Lesions Masquerading as Seborrheic Keratoses
por: Diep, Darlene, et al.
Publicado: (2021)